Jaffetilchin Investment Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-40
Closed -$3.35K 500
2024
Q3
$3.35K Buy
+40
New +$3.15K ﹤0.01% 1106
2019
Q3
Sell
-5,405
Closed -$232K 221
2019
Q2
$232K Sell
5,405
-6,329
-54% -$243K 0.05% 227
2019
Q1
$450K Buy
11,734
+3,116
+36% +$119K 0.1% 169
2018
Q4
$305K Sell
8,618
-410
-5% -$14.9K 0.08% 180
2018
Q3
$348K Buy
9,028
+410
+5% +$14.3K 0.07% 204
2018
Q2
$282K Buy
8,618
+120
+1% +$3.62K 0.06% 234
2018
Q1
$232K Buy
+8,498
New +$231K 0.05% 285
2016
Q4
Sell
-12,536
Closed -$298K 249
2016
Q3
$298K Sell
12,536
-2,860
-19% -$68.2K 0.09% 170
2016
Q2
$360K Buy
+15,396
New +$333K 0.11% 149
2015
Q2
Sell
-20,198
Closed -$359K 203
2015
Q1
$359K Sell
20,198
-3,795
-16% -$60K 0.11% 145
2014
Q4
$318K Buy
+23,993
New +$307K 0.11% 158

Other funds holding BSX

Jaffetilchin Investment Partners's BSX Position: Q4 2024 in Review

Jaffetilchin Investment Partners sold out of Boston Scientific (BSX) in Q4 2024, closing a stake of 40 shares — an estimated $3.35K sold.

Jaffetilchin Investment Partners first reported a position in BSX in Q4 2014 and held it in 11 quarters. The position peaked at $450K in Q1 2019. 1,513 funds tracked by Wall St. Rank hold BSX as of Q4 2024.

  • Jaffetilchin Investment Partners reported no remaining Boston Scientific position as of Q4 2024 after selling out during the quarter.
  • Jaffetilchin Investment Partners sold 40 Boston Scientific shares in Q4 2024, an estimated $3.35K.
  • Jaffetilchin Investment Partners first reported a position in Boston Scientific in Q4 2014 and held it in 11 quarters.
  • Jaffetilchin Investment Partners's Boston Scientific position peaked at $450K in Q1 2019.
  • 1,513 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2024.

Based on Jaffetilchin Investment Partners's 13F filing for Q4 2024, filed 13 Feb 2025.